In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...

SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

The Dexcom G7 is a continuous glucose monitoring (CGM) system designed to help individuals with diabetes manage their blood sugar levels more effectively. This advanced device provides real-time ...

Glucose-monitor vendor DexCom announced a pairing Tuesday with the seller of Oura smart rings. Apps available in the first half of next year will combine DexCom blood-glucose readings with the ...

SEBERANG PERAI, Nov 12 — Dexcom Inc, a leader in continuous glucose monitoring technology, officially opened its first manufacturing facility outside the United States in Penang today. The medical ...

Oura and Dexcom have announced a strategic partnership Dexcom data will be visible inside Oura's application Dexcom says it will invest $75 million in Oura's Series D funding ...